Cours BioTime, Inc. Nyse
Actions
US09066L1052
Recherche biotechnologique et médicale
CA 2024 * | 12,22 M 11,02 M | CA 2025 * | 5,87 M 5,29 M | Capitalisation | 196 M 177 M |
---|---|---|---|---|---|
Résultat net 2024 * | -24 M -21,63 M | Résultat net 2025 * | -35 M -31,55 M | VE / CA 2024 * | 16,1 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 33,5 x |
PER 2024 * |
-8,38
x | PER 2025 * |
-6,34
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 99,57% |
Dernier transcript sur BioTime, Inc.
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 53 | 17/09/18 |
Jill Howe
DFI | Director of Finance/CFO | 48 | 14/11/22 |
Chief Operating Officer | - | 01/01/10 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 58 | 01/07/09 |
Brian Culley
CEO | Chief Executive Officer | 53 | 17/09/18 |
Director/Board Member | 66 | 11/04/14 |
Varia. 1 janv. | Capi. | |
---|---|---|
+29,77% | 49,18 Md | |
+1,00% | 42,11 Md | |
+50,47% | 40,37 Md | |
-5,26% | 28,85 Md | |
+13,68% | 26,09 Md | |
-22,99% | 18,71 Md | |
+8,22% | 13,26 Md | |
+32,41% | 12,32 Md | |
-1,62% | 11,99 Md |